Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (7787)	4/24/1998 3:36:00 PM
From: Hank	Read Replies (1) \| Respond to of 18691

Correction: the statement made by Ferguson in the street.com article referred to the frequency of successful sexual intercourse attempts by men on Vasomax versus Viagra not simply the improvement of erections. According to the Viagra web page, attempts at intercourse were successful 50% of the time with patients on Viagra according to patient diaries (including the placebo effect). This is equivalent to the type of comparison that Ferguson was referring to. However, Pfizer states that their clinical studies involved men suffering from varying degrees of ED whereas the studies quoted in the Journal of Urology abstract states that studies on Vasomax were conducting using men suffering from mild or minimal ED. Therefore, the comparison of successful attempts at sexual intercourse between Vasomax and Viagra is still misleading and imprecise. I'm sorry if I confused anyone.